Site icon Nairametrics

DEAL: Remedial Health, Nigerian health-tech start-up, raises $4.4 million in seed round

Remedial Health

Nigerian health-tech start-up, Remedial Health has raised $4.4 million in a seed round. The company says the funding will be deployed to accelerate its expansion across Nigeria and to provide access to credit for inventory purchases for its growing customer base of neighbourhood pharmacies and hospitals.

The latest round was led by Global Ventures, the VC firm that co-led its pre-seed round, with participation from Tencent, Y Combinator, Cathexis Ventures, LightSpeed Venture Partners Scout Fund, Ventures Platform, Alumni Ventures and True Capital Management, and a number of angel investors, including Guillaume Luccisano and Christopher Golda.

Founded by Samuel Okwuada (CEO) and Victor Benjamin (COO) in 2020, Remedial Health makes it easy for pharmacies to source pharmaceutical products from major manufacturers and distributors, including GSK, Pfizer and AstraZeneca, as well as Nigeria’s Orange Drugs, Emzor and Fidson Healthcare.

By enabling neighbourhood pharmacies and hospitals to source from certified merchants, the start-up brings in new efficiencies to the pharmaceutical value chains and stems the supply of fake and substandard products. Its inventory financing and loans features help its clients to increase their basket sizes, and improve their operating efficiencies.

What they are saying

Commenting on the fundraising, Okwuada said since the beginning of the year, the start-up has grown in leaps owing to the uptake of its digital offering, buy-now-pay-later product, and expansion activities.

News continues after this ad

Global Ventures Principal, Sacha Haider said: “The market opportunity to serve community pharmacies across Africa is significant. In Nigeria alone, 500,000 comunity pharmacies drive over 80% of a 70-billion-dollar market in annual pharmaceutical sales. The team at Rememdial Health is proactively addressing challenges, including price opacity, poor drug quality control and a very fragmented supply chain though a tech-enabled, pharmacy-centered healthcare network that has allowed over 25% in cost reductions at the point of care.”

What you should know

Exit mobile version